Similarly, Ieni et al. [21] showed higher HER-2 expression among tubular and papillary adenocarcinoma compared to other histologic types. A critical challenge in assessing HER-2 status is the inherent tumor heterogeneity observed in gastric and gastroesophageal carcinomas. Here, ERBB2 is linked to papillary adenocarcinoma.